๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
587 medicines starting with โ€œLโ€
MedicineActive substanceLicence holderStatus
Losartan Potassium Pinewood 100 mg film-coated tablets
PA0281/154/003
Losartan potassium Pinewood Laboratories Limited Marketed
Losartan Potassium Pinewood 50 mg film-coated tablets
PA0281/154/002
Losartan potassium Pinewood Laboratories Limited Marketed
Losartan Rowa 100mg film-coated tablets
PA0074/082/003
Losartan potassium Rowa Pharmaceuticals Limited, Marketed
Losartan Rowa 50mg film-coated tablets
PA0074/082/002
Losartan potassium Rowa Pharmaceuticals Limited, Marketed
Losartan Teva 100 mg Film-coated Tablets
PA0749/090/004
Losartan potassium Teva Pharma B.V. Marketed
Losartan Teva 50 mg Film-coated Tablets
PA0749/090/003
Losartan potassium Teva Pharma B.V. Marketed
Losartan/Hydrochlorothiazide Clonmel 100 mg/25 mg film-coated tablets
PA0126/354/002
Losartan potassium, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Losartan/Hydrochlorothiazide Clonmel 50 mg/12.5 mg film-coated tablets
PA0126/354/001
Losartan potassium, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Losartan/Hydrochlorothiazide Krka 100 mg/12.5 mg film-coated tablets
PA1347/040/002
Losartan potassium, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Losartan/Hydrochlorothiazide Krka 100 mg/25 mg film-coated tablets
PA1347/040/003
Losartan potassium, Hydrocholothiazide KRKA, d.d., Novo mesto Marketed
Losartan/Hydrochlorothiazide Krka 50 mg/12.5 mg film-coated tablets
PA1347/040/001
Losartan potassium, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Losartan/Hydrochlorothiazide Teva 100mg/25mg Film-Coated Tablets
PA0749/026/002
Losartan potassium, Hydrochlorothiazide Teva Pharma B.V. Marketed
Losartan/Hydrochlorothiazide Teva 50mg/12.5mg Film-Coated Tablets
PA0749/026/001
Losartan potassium, Hydrochlorothiazide Teva Pharma B.V. Marketed
Losec Control 20 mg gastro-resistant tablets
PA1410/066/001
Omeprazole magnesium Bayer Limited Marketed
Losec MUPS 10 mg gastro-resistant tablets
PA2239/009/001
Omeprazole magnesium CHEPLAPHARM Arzneimittel GmbH Marketed
Losec MUPS 10 mg gastro-resistant tablets
PPA0465/423/003
Omeprazole PCO Manufacturing Ltd. Marketed
Losec MUPS 10 mg gastro-resistant tablets
PPA1463/141/002
Omeprazole IMED Healthcare Ltd., โ€”
Losec MUPS 20 mg gastro-resistant tablets
PA2239/009/002
Omeprazole magnesium CHEPLAPHARM Arzneimittel GmbH Marketed
Losec MUPS 20 mg gastro-resistant tablets
PPA0465/423/001
Omeprazole PCO Manufacturing Ltd. โ€”
Losec MUPS 20 mg gastro-resistant tablets
PPA1463/141/001
Omeprazole IMED Healthcare Ltd., โ€”
Losec MUPS 40 mg gastro-resistant tablets
PA2239/009/003
Omeprazole magnesium CHEPLAPHARM Arzneimittel GmbH Marketed
Loseina 10 mg hard gastro-resistant capsules
PA0281/272/001
Omeprazole Pinewood Laboratories Limited Not marketed
Loseina 20 mg hard gastro-resistant capsules
PA0281/272/002
Omeprazole Pinewood Laboratories Limited Marketed
Loseina 40 mg hard gastro-resistant capsules
PA0281/272/003
Omeprazole Pinewood Laboratories Limited Marketed
Lotanos Comp 100 mg/25 mg film-coated tablets
PA0074/072/002
Losartan potassium, Hydrochlorothiazide Rowa Pharmaceuticals Limited, Marketed
Lotanos Comp 50 mg/12.5 mg film-coated tablets
PA0074/072/001
Losartan potassium, Hydrochlorothiazide Rowa Pharmaceuticals Limited, Marketed
Lotemax 0.5% w/v eye drops, suspension
PA1245/001/001
Loteprednol etabonate Dr. Gerhard Mann, chem.-pharm. Fabrik GmbH Not marketed
Low Centyl K 1.25 mg/573 mg modified-release tablets
PA22650/002/001
Bendroflumethiazide, Potassium chloride Karo Pharma AB Marketed
Loxentia 20mg hard gastro-resistant capsule
PA1347/051/001
Duloxetine KRKA, d.d., Novo mesto Marketed
Loxentia 40mg hard gastro-resistant capsule
PA1347/051/003
Duloxetine KRKA, d.d., Novo mesto Marketed
Lubion 25 mg solution for injection in pre-filled syringe
PA1104/006/001
Progesterone IBSA Farmaceutici Italia S.r.l Marketed
Lubion 25 mg solution for injection in pre-filled syringe
PPA0465/524/001
Progesterone PCO Manufacturing Ltd. โ€”
Lucentis 10 mg/ml solution for injection
EU/1/06/374/002-004
Ranibizumab Novartis Europharm Limited โ€”
Lumeblue 25 mg prolonged-release tablets
EU/1/20/1470/001
Methylthioninium chloride Alfasigma S.p.A โ€”
Lumigan 0.1 mg/ml eye drops, solution
EU/1/02/205/3-4
Bimatoprost AbbVie Deutschland GmbH & Co. KG โ€”
Lumigan 0.3 mg/ml eye drops, solution
EU/1/02/205/001-2
Bimatoprost AbbVie Deutschland GmbH & Co. KG โ€”
Luminity 150 microlitres/ml gas and solvent for dispersion for injection/infusion
EU/1/06/361/01-2
Perflutren Lantheus EU Limited โ€”
Lumobry 0.25 mg/mL eye drops, solution
PA23259/024/001
Brimonidine tartrate Bausch + Lomb Ireland Limited Not marketed
LUMYKRAS 120 mg film-coated tablets
EU/1/21/1603/001-003
Sotorasib Amgen Europe B.V., โ€”
LUMYKRAS 240 mg film-coated tablets
EU/1/21/1603/004
Sotorasib Amgen Europe B.V., โ€”
Lunsumio 1 mg concentrate for solution for infusion
EU/1/22/1649/001
Mosunetuzumab Roche Registration GmbH โ€”
Lunsumio 30 mg concentrate for solution for infusion
EU/1/22/1649/002
Mosunetuzumab Roche Registration GmbH โ€”
Lunsumio 45 mg solution for injection
EU/1/22/1649/004
Mosunetuzumab Roche Registration GmbH โ€”
Lunsumio 5 mg solution for injection
EU/1/22/1649/003
Mosunetuzumab Roche Registration GmbH โ€”
Lupkynis 7.9 mg soft capsules
EU/1/22/1678/001
Voclosporin Otsuka Pharmaceutical Netherlands B.V. โ€”
Lustral 100 mg film-coated tablets
PA23355/048/002
Sertraline Viatris Healthcare Limited Marketed
Lustral 100 mg film-coated tablets
PPA0465/062/002
Sertraline hydrochloride PCO Manufacturing Ltd. โ€”
Lustral 50 mg film-coated tablets
PA23355/048/001
Sertraline Viatris Healthcare Limited Marketed
Lustral 50 mg film-coated tablets
PPA0465/062/001
Sertraline hydrochloride PCO Manufacturing Ltd. โ€”
Lutathera 370 MBq/mL solution for infusion
EU/1/17/1226/001
177lu-dotao-tyr3-octeeotate Advanced Accelerator Applications โ€”
โ† 8 9 10 11 12 โ†’
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.